WILHELMUS CM GROENHUYSEN Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILHELMUS CM GROENHUYSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of WILHELMUS CM GROENHUYSEN for March 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.04 | 37,461 | 1,762,165 | 37,461 | |
Mar 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 0.00 | 20,461 | 0 | 86,725 | 66.3 K to 86.7 K (+30.88 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 31,234 | 107,445 | 244,663 | |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 40,000 | 137,600 | 275,897 | |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 18,766 | 64,555 | 315,897 | |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.40 | 31,234 | 1,668,021 | 66,264 | 97.5 K to 66.3 K (-32.04 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 31,234 | 107,445 | 97,498 | 66.3 K to 97.5 K (+47.14 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 56.50 | 4,342 | 245,336 | 66,264 | 70.6 K to 66.3 K (-6.15 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 55.95 | 2,800 | 156,654 | 70,606 | 73.4 K to 70.6 K (-3.81 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 54.54 | 2,800 | 152,720 | 73,406 | 76.2 K to 73.4 K (-3.67 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.82 | 4,207 | 226,404 | 76,206 | 80.4 K to 76.2 K (-5.23 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 52.90 | 25,851 | 1,367,595 | 80,413 | 106.3 K to 80.4 K (-24.33 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 40,000 | 137,600 | 106,264 | 66.3 K to 106.3 K (+60.36 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 56.52 | 5,222 | 295,153 | 66,264 | 71.5 K to 66.3 K (-7.30 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 56.04 | 4,748 | 266,054 | 71,486 | 76.2 K to 71.5 K (-6.23 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 54.56 | 3,400 | 185,497 | 76,234 | 79.6 K to 76.2 K (-4.27 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.91 | 5,396 | 290,877 | 79,634 | 85 K to 79.6 K (-6.35 %) |
Mar 06 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 18,766 | 64,555 | 85,030 | 66.3 K to 85 K (+28.32 %) |
Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,717 | 0 | 15,431 | |
Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,717 | 0 | 15,431 | |
Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.68 | 3,288 | 176,500 | 66,264 | 69.6 K to 66.3 K (-4.73 %) |
Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 53.68 | 3,288 | 176,500 | 66,264 | 69.6 K to 66.3 K (-4.73 %) |
Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 52.90 | 7,717 | 408,229 | 69,552 | 61.8 K to 69.6 K (+12.48 %) |
Mar 01 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 52.90 | 7,717 | 408,229 | 69,552 | 61.8 K to 69.6 K (+12.48 %) |